N-[16-(2-amino-2-oxoethyl)-13-[(4-hydroxyphenyl)methyl]-32-methyl-22,27-bis(2-methylpropyl)-2,6,12,15,18,21,24,26,29-nonaoxo-5-oxa-1,11,14,17,20,23,28-heptazatricyclo[28.3.0.07,11]tritriacontan-3-yl]-2-(butanoylamino)-3-methylpentanamide
| Internal ID | 35e71503-8914-4760-b7b1-c41e0c217901 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | N-[16-(2-amino-2-oxoethyl)-13-[(4-hydroxyphenyl)methyl]-32-methyl-22,27-bis(2-methylpropyl)-2,6,12,15,18,21,24,26,29-nonaoxo-5-oxa-1,11,14,17,20,23,28-heptazatricyclo[28.3.0.07,11]tritriacontan-3-yl]-2-(butanoylamino)-3-methylpentanamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C53H80N10O14/c1-9-12-43(67)61-46(31(8)10-2)50(73)60-38-27-77-53(76)39-13-11-18-62(39)51(74)37(22-32-14-16-33(64)17-15-32)59-48(71)36(23-42(54)66)57-45(69)25-55-47(70)35(20-29(5)6)56-44(68)24-41(65)34(19-28(3)4)58-49(72)40-21-30(7)26-63(40)52(38)75/h14-17,28-31,34-40,46,64H,9-13,18-27H2,1-8H3,(H2,54,66)(H,55,70)(H,56,68)(H,57,69)(H,58,72)(H,59,71)(H,60,73)(H,61,67) |
| InChI Key | VJNXGGVCMFEVSM-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C53H80N10O14 |
| Molecular Weight | 1081.30 g/mol |
| Exact Mass | 1080.58554726 g/mol |
| Topological Polar Surface Area (TPSA) | 351.00 Ų |
| XlogP | 2.30 |
| Atomic LogP (AlogP) | -0.48 |
| H-Bond Acceptor | 14 |
| H-Bond Donor | 9 |
| Rotatable Bonds | 15 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7454 | 74.54% |
| Caco-2 | - | 0.8616 | 86.16% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.7000 | 70.00% |
| Subcellular localzation | Lysosomes | 0.4863 | 48.63% |
| OATP2B1 inhibitior | - | 0.8541 | 85.41% |
| OATP1B1 inhibitior | + | 0.8221 | 82.21% |
| OATP1B3 inhibitior | + | 0.9378 | 93.78% |
| MATE1 inhibitior | - | 0.8800 | 88.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9052 | 90.52% |
| P-glycoprotein inhibitior | + | 0.7493 | 74.93% |
| P-glycoprotein substrate | + | 0.9150 | 91.50% |
| CYP3A4 substrate | + | 0.7340 | 73.40% |
| CYP2C9 substrate | + | 0.5868 | 58.68% |
| CYP2D6 substrate | - | 0.8193 | 81.93% |
| CYP3A4 inhibition | - | 0.9102 | 91.02% |
| CYP2C9 inhibition | - | 0.9498 | 94.98% |
| CYP2C19 inhibition | - | 0.9234 | 92.34% |
| CYP2D6 inhibition | - | 0.8931 | 89.31% |
| CYP1A2 inhibition | - | 0.9498 | 94.98% |
| CYP2C8 inhibition | + | 0.7897 | 78.97% |
| CYP inhibitory promiscuity | - | 0.9681 | 96.81% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6174 | 61.74% |
| Eye corrosion | - | 0.9882 | 98.82% |
| Eye irritation | - | 0.8997 | 89.97% |
| Skin irritation | - | 0.7824 | 78.24% |
| Skin corrosion | - | 0.9267 | 92.67% |
| Ames mutagenesis | - | 0.6700 | 67.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3642 | 36.42% |
| Micronuclear | + | 0.8900 | 89.00% |
| Hepatotoxicity | + | 0.5125 | 51.25% |
| skin sensitisation | - | 0.8723 | 87.23% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | + | 0.5212 | 52.12% |
| Acute Oral Toxicity (c) | III | 0.4550 | 45.50% |
| Estrogen receptor binding | + | 0.8185 | 81.85% |
| Androgen receptor binding | + | 0.7143 | 71.43% |
| Thyroid receptor binding | + | 0.5792 | 57.92% |
| Glucocorticoid receptor binding | + | 0.5935 | 59.35% |
| Aromatase binding | + | 0.6767 | 67.67% |
| PPAR gamma | + | 0.7966 | 79.66% |
| Honey bee toxicity | - | 0.7040 | 70.40% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5000 | 50.00% |
| Fish aquatic toxicity | + | 0.7820 | 78.20% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.96% | 98.95% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.16% | 97.25% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.11% | 94.45% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.79% | 96.09% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 97.64% | 83.82% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 96.80% | 82.38% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 96.04% | 95.00% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 94.93% | 96.11% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.77% | 97.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.73% | 90.08% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 94.63% | 93.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.23% | 94.66% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.95% | 95.89% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.68% | 91.11% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.46% | 97.64% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 93.15% | 90.93% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.58% | 96.61% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.41% | 99.17% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.25% | 97.14% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 92.06% | 97.23% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.23% | 90.71% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.39% | 95.50% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 89.37% | 96.90% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 89.32% | 100.00% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 89.15% | 85.14% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 88.52% | 100.00% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 87.71% | 96.69% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 86.87% | 83.14% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 86.83% | 94.80% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 86.74% | 96.33% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 86.38% | 96.31% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 86.12% | 98.59% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 86.05% | 89.00% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 86.04% | 94.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.02% | 93.56% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 85.72% | 92.97% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 85.24% | 85.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.03% | 95.56% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 84.28% | 91.19% |
| CHEMBL3837 | P07711 | Cathepsin L | 83.32% | 96.61% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 83.26% | 98.05% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 82.60% | 93.10% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 82.56% | 92.88% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 82.26% | 99.23% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 81.64% | 95.83% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 81.62% | 89.50% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 81.44% | 82.69% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 80.92% | 94.33% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 80.55% | 95.42% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 44123305 |
| LOTUS | LTS0095383 |
| wikiData | Q104199517 |